Claro’s patented SpectraWave system has been developed to leverage core hardware and software components to answer the critical need for timely, accurate and actionable healthcare information. The same core system can also be used in important research only and non-medical applications including protein and cellular analysis, environmental analysis and biodefense. Claro has developed SpectraWave to be a disruptive system, redefining how optics can be applied to medical diagnostic and patient monitoring applications. Claro’s breakthrough is in delivering a powerful combination of unique and confirmatory information by integrating several discrete optical analysis methods. This innovation means SpectraWave can achieve the levels of sensitivity and specificity and limits of detection needed to meet today’s hospital laboratory requirements. Depending on sample preparation requirements, the time to result ranges from a few seconds to less than five minutes. The SpectraWave system is portable and reagentless, meaning the same technology can be used in the laboratory, in the clinic and in the field. Whether focused on patients, products or processes, users will benefit from improved quality, better outcomes and cost savings.